Stifel Financial’s Sophiris Bio, Inc. SPHS Stock Holding History

Stifel Financial’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-14,825	Closed	-$49K	–	2349
2014 Q1	$49K	Buy	+14,825	New	+$58.1K	﹤0.01%	2046

Other funds holding SPHS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Stifel Financial's SPHS Position: Q2 2014 in Review

Stifel Financial sold out of Sophiris Bio, Inc. (SPHS) in Q2 2014, closing a stake of 14,825 shares — an estimated $49K sold.

Stifel Financial first reported a position in SPHS in Q1 2014 and held it in 1 quarter. The position peaked at $49K in Q1 2014. 18 funds tracked by Wall St. Rank hold SPHS as of Q2 2014.

Stifel Financial reported no remaining Sophiris Bio, Inc. position as of Q2 2014 after selling out during the quarter.
Stifel Financial sold 14,825 Sophiris Bio, Inc. shares in Q2 2014, an estimated $49K.
Stifel Financial first reported a position in Sophiris Bio, Inc. in Q1 2014 and held it in 1 quarter.
Stifel Financial's Sophiris Bio, Inc. position peaked at $49K in Q1 2014.
18 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q2 2014.

Based on Stifel Financial's 13F filing for Q2 2014, filed 14 Aug 2014.